← Back to ORIC

Oric Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 03/08/2026Mar 2026Filed 04/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 03/08/2026Mar 2025Filed 04/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 05/05/2025
−$41−$36−$33−$36−$30−$35−$32−$25
−$0.38−$0.34−$0.33−$0.47−$0.42−$0.49−$0.45−$0.37
108105997871717067

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.